New lung cancer drug enters Mid-Stage testing

NCT ID NCT07019675

Summary

This study is testing whether a new drug called SKB518 can help control lung cancer. About 192 adults with either non-small cell or small cell lung cancer will receive the drug until their cancer worsens or side effects become too severe. Researchers will measure how well the drug shrinks tumors, how long it keeps cancer from progressing, and what side effects patients experience.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Cancer Hospital of Xinjiang Medical University

    RECRUITING

    Ürümqi, Xinjiang, China

    Contact

  • Cancer Hospital Chinese Academy of Medical Science

    RECRUITING

    Beijing, China

    Contact Email: •••••@•••••

  • Cancer Hospital of Guangxi Medical University

    RECRUITING

    Nanning, Guangxi, China

    Contact

  • Cancer Hospital of Shandong First Medical University

    RECRUITING

    Jinan, Shandong, China

    Contact

  • Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center

    RECRUITING

    Shenzhen, Guangdong, China

    Contact

  • Hubei Cancer Hospital

    RECRUITING

    Wuhan, Hubei, China

    Contact

  • Hunan Cancer Hospital

    RECRUITING

    Changsha, Hunan, China

    Contact

    Contact

  • Jiangxi Cancer Hospital

    RECRUITING

    Nanchang, Jiangxi, China

    Contact

  • Renmin Hospital of Wuhan University

    RECRUITING

    Wuhan, Hubei, China

    Contact

  • Shanghai Pulmonary Hospital (Affiliated to Tongji University)

    RECRUITING

    Shanghai, China

    Contact

  • Shanxi Cancer Hospital

    RECRUITING

    Taiyuan, Shanxi, China

    Contact

  • Taizhou Hospital of Zhejiang Province

    RECRUITING

    Taizhou, Zhejiang, China

    Contact

  • The First Affiliated Hospital of Zhengzhou University

    RECRUITING

    Zhengzhou, Henan, China

    Contact

  • Tianjin Medical University Cancer Institute & Hospital

    RECRUITING

    Tianjin, China

    Contact

  • Xiangyang Central Hospital

    RECRUITING

    Xiangyang, Hubei, China

    Contact

  • Yunnan Cancer Hospital

    RECRUITING

    Kunming, Yunnan, China

    Contact

  • Zhejiang Cancer Hospital

    RECRUITING

    Hangzhou, Zhejiang, China

    Contact

Conditions

Explore the condition pages connected to this study.